William Mack & Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Buy
1,364
+12
+0.9% +$3.78K 0.15% 59
2026
Q1
$444K Sell
1,352
-231
-15% -$82.9K 0.25% 41
2025
Q4
$556K Sell
1,583
-6
-0.4% -$2.19K 0.26% 40
2025
Q3
$587K Sell
1,589
-2
-0.1% -$773 0.32% 38
2025
Q2
$629K Hold
1,591
0.4% 35
2025
Q1
$592K Sell
1,591
-52
-3% -$19.8K 0.51% 30
2024
Q4
$592K Buy
+1,643
New +$609K 0.62% 29

Other funds holding SYK

William Mack & Associates's SYK Position: Q2 2026 in Review

William Mack & Associates increased its Stryker (SYK) stake by 0.89% in Q2 2026, buying an estimated $3.78K and bringing the position to 1,364 shares worth $429K. The position accounts for 0.15% of the portfolio, ranked #59.

William Mack & Associates first reported a position in SYK in Q4 2024 and has held it in 7 quarters since. The position peaked at $629K in Q2 2025. 2,257 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • William Mack & Associates held 1,364 shares of Stryker worth $429K as of Q2 2026.
  • William Mack & Associates bought 12 Stryker shares in Q2 2026, an estimated $3.78K.
  • Stryker made up 0.15% of William Mack & Associates's portfolio in Q2 2026, its #59 holding.
  • William Mack & Associates first reported a position in Stryker in Q4 2024 and has held it in 7 quarters since.
  • William Mack & Associates's Stryker position peaked at $629K in Q2 2025.
  • 2,257 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on William Mack & Associates's 13F filing for Q2 2026, filed 10 Jul 2026.